1-5 of 5
José Hernández
Close
Sort by
Journal Articles

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

Maria-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel T Hernández, Javier de la Rubia, Juan José Lahuerta, MD, PhD, Pilar Giraldo, MD, Joan Bargay, MD, Laura Rosiñol, Albert Oriol, MD, Jose García-Laraña, Luis Palomera, Felipe de Arriba, Felipe Prosper, MD, Mariluz Martino, MD, Ana-Isabel Teruel, José Hernández, Graça Esteves, Mario Mariz, Adrian Alegre, MD, J.L. Guzmán, Nuria Quintana, Jose-Luis Garcia, Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 614.
https://doi.org/10.1182/blood.V114.22.614.614
Published: 2009
Journal Articles

A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years.

Maria-Victoria Mateos, MD, PhD, Albert Oriol, MD, Joaquin Martinez, MD, M Teresa Cibeira, Norma C. Gutiérrez, Maria Jose Terol, MD, Raquel de Paz, MD, PhD, Jose García-Laraña, Enrique Bengoechea, Alejandro Martín García-Sancho, Rafael Martínez, Luis Palomera, Felipe de Arriba, Yolanda Gonzalez, José Hernández, Anna Sureda, MD, PhD, Jose-Luis Bello, Juan José Lahuerta, MD, PhD, Joan Blade, M.D., Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3.
https://doi.org/10.1182/blood.V114.22.3.3
Published: 2009
Journal Articles

Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade- Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?

Maria-Victoria Mateos, Albert Oriol, Joaquín Martínez, Ma Teresa Cibeira, Raquel de Paz, Ma José Terol, José García-Laraña, Enrique Bengoechea, Rafael Martínez, Alejandro Martin, Felipe de Arriba, Luis Palomera, José Hernández, Jose-Luis Bello, María-Luisa Martín, Yolanda González, Joan Blade, MD, Juan José Lahuerta, J.F San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 651.
https://doi.org/10.1182/blood.V112.11.651.651
Published: 2008
Journal Articles

Multiparameter Flow Cytometry Remission Is the Most Relevant Prognostic Factor for Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Bruno Paiva, Maria-Belén Vidriales, Jorge Cerveró, Gema Mateo, Jose J. Pérez, Maria Angeles Montalbán, Anna Sureda, Laura Montejano, Norma C. Gutiérrez, Alfonso García de Coca, Natalia de las Heras, MD, Maria Victoria Mateos, Maria-Consuelo López-Berges, Raimundo García-Boyero, Josefina Galende, José Hernández, Luis Palomera, Dolores Carrera, Rafael Martínez, Javier de la Rubia, Alejandro Martín, Joan Blade, Juan José Lahuerta, Alberto Orfao, J. F. San Miguel, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 737.
https://doi.org/10.1182/blood.V112.11.737.737
Published: 2008
Journal Articles

Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome

Brief Report
Jesús F. San Miguel, Julia Almeida, Gema Mateo, Joan Bladé, Consuelo López-Berges, Dolores Caballero, José Hernández, Marı́a Jesús Moro, Javier Fernández-Calvo, Joaquı́n Dı́az-Mediavilla, Luis Palomera, Alberto Orfao
Journal: Blood
Blood (2002) 99 (5): 1853–1856.
https://doi.org/10.1182/blood.V99.5.1853
Published: 2002